Category: New products
-
Zika Virus Cloned for Drug, Vaccine Development
17 May 2016. Researchers in Texas produced a genetically-engineered clone of the Zika virus to provide a testing platform for developers of diagnostics, vaccines, and treatments for the growing outbreak. The team from University of Texas Medical Branch in Galveston, led by geneticist Pei-Yong Shi, reported its findings yesterday in the journal Cell Host and Microbe.…
-
Smartphone App Helps Deal with Negative Moods
13 May 2016. A smartphone app created at two university psychology departments in the U.K. was shown to reduce the intensity of negative moods among its users. The team from University of Liverpool and University of Manchester reported its findings in the May 2016 issue of the British Journal of Psychiatry Open. The app, called…
-
Ingestible Robot Designed for Stomach Objects, Wounds
13 May 2016. An engineering team at Massachusetts Institute of Technology designed a tiny robotic device for swallowing into the stomach to remove foreign objects and repair wounds. Researchers that include team members at University of Sheffield and University of York in the U.K., as well as Tokyo Institute of Technology, will describe the device…
-
Chip Device Simulates Human Gut Interactions
11 May 2016. A device simulating the human intestine was shown in lab tests to generate similar responses to interactions between gut microbes and cells, as found in humans and animals. The HuMix system — short for Human Microbial Cross Talk — developed by researchers at University of Luxembourg and University of Arizona, is described…
-
Personalized Heart Model Devised for Treatment Decisions
11 May 2016. A medical engineering team developed three-dimensional computer models of the heart that better predict heart rhythm problems requiring an implanted defibrillator than current guidelines. Researchers at Johns Hopkins University led by biomedical engineering professor Natalia Trayanova published its findings yesterday in the journal Nature Communications. Trayanova and colleagues from the Johns Hopkins…
-
Vaccine Shown to Give 1-Year Malaria Protection
10 May 2016. An early-stage clinical trial with healthy volunteers shows an experimental vaccine can protect against malaria infection for as long as 1 year. Results of the trial, conducted by National Institute of Allergy and Infectious Diseases, or NIAID, part of National Institutes of Health, and University of Maryland Medical Center in Baltimore, appear…
-
MIT Spin-Off Develops Material Mimicking Human Skin
9 May 2016. A substance that emulates properties of youthful human skin was shown in pilot tests with human subjects to outperform other materials used for wound dressings. The new polymer material, based on research at Massachusetts Institute of Technology and commercialized by Olivo Laboratories, a start-up enterprise, is described in today’s issue of the…
-
566 New Drugs in Pipeline for Orphan Diseases
9 May 2016. A report by an industry group says 566 drugs designed to treat rare diseases are now in clinical testing by pharmaceutical companies. The report, prepared by Pharmaceutical Research and Manufacturers of America, or PhRMA, and the ALS Association, credits many of these new drugs to incentives in legislation encouraging research and development…
-
Genomics, Data Tools Track MRSA Outbreaks in Europe
6 May 2016. A combination of whole-genome sequencing and data visualization tools now makes it possible to track the spread of antibiotic-resistant bacteria in European health facilities. A Europe-wide team led by Wellcome Trust Sanger Institute and Imperial College London described their software and service yesterday in the journal mBio. The authors call the spread…
-
Trial Underway Testing Antibody for Celiac Disease
5 May 2016. A clinical trial testing an engineered antibody therapy for celiac disease in people that do not respond to a gluten-free diet began treating its first patients. The trial is conducted by Celimmune LLC, a biopharmaceutical company in in Lebanon, New Jersey, but patients are recruited in Finland, where the rate of celiac…